Three distinct genotypes within Candida parapsilosis from clinical sources

Area of Science:

• Medical Mycology
• Molecular Biology
• Clinical Microbiology

Background:

• Candida parapsilosis is an opportunistic fungal pathogen causing various infections.
• Accurate identification and differentiation of Candida species are crucial for effective treatment.
• Previous classifications relied on phenotypic characteristics, which can be unreliable.

Purpose of the Study:

• To genetically differentiate clinical isolates of Candida parapsilosis.
• To investigate the genetic relatedness of different C. parapsilosis groups.
• To assess the utility of isoenzyme profiles and DNA sequencing for Candida parapsilosis typing.

Main Methods:

• Isoenzyme electrophoresis was used to analyze protein profiles of isolates.
• DNA sequencing of internally transcribed spacer (ITS) regions (ITS1 and ITS2) was performed.
• Phenotypic characterization using the API 20C kit and antifungal susceptibility testing were conducted.

Main Results:

• Three distinct genetic groups (I, II, and III) of C. parapsilosis were identified.
• Group I comprised the majority of common clinical isolates, including the type strain.
• While ITS2 sequences showed minor differences, ITS1 sequences revealed significant variations between groups.
• D-xylitol assimilation differed between groups on the API 20C kit, but all assimilated it from broth.
• Secreted proteinase activity varied among the groups, with Group I showing higher activity.
• Antifungal susceptibility testing did not differentiate the groups.

Conclusions:

• Isoenzyme profiles and ITS1 DNA sequencing are effective methods for differentiating C. parapsilosis groups.
• Genetic grouping provides insights into the population structure of C. parapsilosis clinical isolates.
• Further research into the clinical significance of these genetic groups is warranted.